Source: Current Medicinal Chemistry. Unidade: FCFRP
Subjects: TRYPANOSOMA, LEISHMANIA, PLASMODIUM, PRODUTOS NATURAIS, FÁRMACOS DE ORIGEM VEGETAL (PESQUISA;DESENVOLVIMENTO)
ABNT
SCHMIDT, T. J. et al. The potential of secondary metabolites from plants as drugs or leads against protozoan neglected diseases: Part I. Current Medicinal Chemistry, v. 19, n. 14, p. 2128-2175, 2012Tradução . . Acesso em: 27 ago. 2024.APA
Schmidt, T. J., Khalid, S. A., Romanha, A. J., Alves, T. M. A., Biavatti, M. W., Brun, R., et al. (2012). The potential of secondary metabolites from plants as drugs or leads against protozoan neglected diseases: Part I. Current Medicinal Chemistry, 19( 14), 2128-2175.NLM
Schmidt TJ, Khalid SA, Romanha AJ, Alves TMA, Biavatti MW, Brun R, Costa FB da, Castro SL de, Ferreira VF, Lacerda MVG de, Lago JHG, Leon LL, Lopes NP, Amorim RC das N, Niehues M, Ogungbe IV, Pohlit AM, Scotti MT, Setzer WN, Soeiro M de NC, Steindel M, Tempone AG. The potential of secondary metabolites from plants as drugs or leads against protozoan neglected diseases: Part I. Current Medicinal Chemistry. 2012 ; 19( 14): 2128-2175.[citado 2024 ago. 27 ]Vancouver
Schmidt TJ, Khalid SA, Romanha AJ, Alves TMA, Biavatti MW, Brun R, Costa FB da, Castro SL de, Ferreira VF, Lacerda MVG de, Lago JHG, Leon LL, Lopes NP, Amorim RC das N, Niehues M, Ogungbe IV, Pohlit AM, Scotti MT, Setzer WN, Soeiro M de NC, Steindel M, Tempone AG. The potential of secondary metabolites from plants as drugs or leads against protozoan neglected diseases: Part I. Current Medicinal Chemistry. 2012 ; 19( 14): 2128-2175.[citado 2024 ago. 27 ]